14/01/2017
"Humisil Gold" - a wide spectrum antitumor immunomodulating agent based on ion gold compounds with a complex of natural humic substances. The supplement is synthesised basing on a bioengineered approach and combined methodology in development of effective measures for prevention and adjuvant therapy of oncological diseases, viral and bacterial infections (including HIV, hepatitis of A, B, C, D types; tuberculosis, syphilis, etc.).
The product has a strong immunomodulating and antineoplastic action and it is effective as adjuvant in prevention and therapy of oncological diseases, complex viral therapy. It represents a complex of positively charged metal-organic gold ions coupled with negatively charged ions of humic acids organic matrix.
Use of metals, first of all gold, is due to presence of high intracellular metabolism of electro-chemical nature during tumor genesis. Influence of ionic forms of gold on a cell affected by oncological disease is determined by influence on thermionic emission processes and conditions of super radicals fission chain reactions. Conditions of radicals fission chain reactions are violated within a poorly differentiated oncological cell and correction of cell molecular structures takes place. Reactions become wan or terminated. In a highly differentiated oncological cell, under conditions of significant surplus of free radicals, we can observe sharp increase in activity of enzymes contained in the cytoplasm of affected cells and its destruction.
Use of humates as organic matrix is due to the presence of a carboxyl group, as well as free hydrogen atoms on adjacent with carboxyl carbon atom, which allows not only to withdraw formed free radicals from the reaction zone, but also to restore the immune system. In particular, quantitative indicators of Т-total, Т-active, Т-helper, Т-cytotoxic, Т-suppressor cells, natural killer cells (NK-cells), leukocytes, macrophages, thrombocytes, eosinophils, basophiles, banded, segmented, monocytes are normalized in blood. It restores immunoglobulin content in blood, decreases erythrocyte sedimentation rate, stimulates production of cytokines, including c-interferons and tumor necrosis factor (TNF-a).
Due to immunomodulatory effect of the compound it can be used also in clinical dermatology for treatment of psoriasis, eczema and other epidermic systemic immunoallergic diseases.
Indications for use:
● necessity of adaptation to influence of different extreme ecologic and/or biologic factors;
● prevention and therapy of oncological diseases; pre- and post-surgical period;
● somatic diseases, infections, intoxications, rehabilitation of pathological conditions following acute and chronic bacterial and viral infections;
● diabetes;
● consequences of heart attacks, strokes;
● neurodegenerative diseases.